EMERGENCY REVERSAL OF ANTICOAGULATION AFTER INTRACEREBRAL HEMORRHAGE

被引:231
作者
FREDRIKSSON, K
NORRVING, B
STROMBLAD, LG
机构
[1] UNIV LUND HOSP,DEPT NEUROL,S-22185 LUND,SWEDEN
[2] UNIV LUND HOSP,DEPT NEUROSURG,S-22185 LUND,SWEDEN
关键词
ANTICOAGULANTS; CEREBRAL HEMORRHAGE;
D O I
10.1161/01.STR.23.7.972
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose: Although intracerebral hemorrhage is one of the most serious complications during oral anticoagulant therapy, there are no guidelines on emergency treatment with respect to reversal of anticoagulation effect in these patients. Methods: We retrospectively compared laboratory data and clinical features in 17 cases of anticoagulant-related intracerebral hemorrhage treated with prothrombin complex concentrate (n=10) or fresh-frozen plasma (n=7). Results: In the group of patients treated with prothrombin complex concentrate, the mean prothrombin time decreased from 2.83 to 1.22 International Normalized Ratio within 4.8 hours, compared with a decrease from 2.97 to 1.74 within 7.3 hours in those given fresh-frozen plasma (i.e., four to five times more rapidly after treatment with prothrombin complex concentrate) (p<0.001). Symptoms and signs of intracerebral hemorrhage, measured on an eight-graded Reaction Level Scale, progressed on average 0.2 grades in patients given prothrombin complex concentrate compared with 1.9 grades in those given fresh-frozen plasma (p<0.05). In patients with prothrombin values above 1.46, clinical progression within 12 hours occurred in five of six cases. Conclusions: Treatment with prothrombin complex concentrate reverses anticoagulation more rapidly than fresh-frozen plasma, which might be of importance for the prevention of further bleeding.
引用
收藏
页码:972 / 977
页数:6
相关论文
共 21 条
[1]   RESUMPTION OF ANTICOAGULATION AFTER INTRACRANIAL BLEEDING IN PATIENTS WITH PROSTHETIC HEART-VALVES [J].
BABIKIAN, VL ;
KASE, CS ;
PESSIN, MS ;
CAPLAN, LR ;
GORELICK, PB .
STROKE, 1988, 19 (03) :407-408
[2]   PURE SUBCORTICAL ARTERIOSCLEROTIC ENCEPHALOPATHY (BINSWANGER DISEASE) - A CLINICOPATHOLOGICAL STUDY .2. PATHOLOGICAL FEATURES [J].
BRUN, A ;
FREDRIKSSON, K ;
GUSTAFSON, L .
CEREBROVASCULAR DISEASES, 1992, 2 (02) :87-92
[3]   ANTICOAGULATION-RELATED INTRACEREBRAL HEMORRHAGE [J].
FORSTING, M ;
MATTLE, HP ;
HUBER, P .
CEREBROVASCULAR DISEASES, 1991, 1 (02) :97-102
[4]   INTRACEREBRAL HEMATOMAS DURING ANTICOAGULANT TREATMENT [J].
FRANKE, CL ;
DEJONGE, J ;
VANSWIETEN, JC ;
DECOUL, AAWO ;
VANGIJN, J .
STROKE, 1990, 21 (05) :726-730
[5]  
HANDLIN RI, 1991, HARRISONS PRINCIPLES, P1511
[6]  
HIRSH J, 1991, NEW ENGL J MED, V324, P1865
[7]   ANTICOAGULANT-RELATED INTRACEREBRAL HEMORRHAGE [J].
KASE, CS ;
ROBINSON, RK ;
STEIN, RW ;
DEWITT, LD ;
HIER, DB ;
HARP, DL ;
WILLIAMS, JP ;
CAPLAN, LR ;
MOHR, JP .
NEUROLOGY, 1985, 35 (07) :943-948
[8]  
Kistler JP, 1991, HARRISONS PRINCIPLES, P1977
[9]  
MASUDA J, 1983, STROKE, V14, P934, DOI 10.1161/01.STR.14.6.934
[10]   ANTICOAGULATION-RELATED INTRACRANIAL EXTRACEREBRAL HEMORRHAGE [J].
MATTLE, H ;
KOHLER, S ;
HUBER, P ;
ROHNER, M ;
STEINSIEPE, KF .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (07) :829-837